Uncategorized
This week in Drug Discovery (16 – 20 March)
News round-up for 16 – 20 March February by Bruno Quinney, Content Team at DDW.
This week, a pioneering method is being used to make drugs for Parkinson’s disease. Elsewhere, advances have been made in both research and trials for common cancers.
The top stories:
Edinburgh team makes Parkinson’s drug from plastic bottles
A drug to treat Parkinson’s disease can be made from waste plastic bottles using a pioneering method, a study shows.
Read more…
Cancer enzyme discovery opens new avenues for drug discovery
Researchers have identified the enzyme DHX8 as a crucial regulator of the stress response protein HSF1, which may have potential to open new avenues for future drug development.
Research identifies new target for multiple myeloma treatment
New research published in the Clinical Lymphoma, Myeloma & Leukemia journal has confirmed that Kappa Myeloma Antigen (KMA) and Lambda Myeloma Antigen (LMA) are promising therapeutic targets for the treatment of multiple myeloma.
First patient dosed in ROR1-positive blood cancer treatment
The first patient has been dosed with NVG-222, a treatment for ROR1-positive blood cancers developed by biotechnology company NovalGen.
Rare disease drugs to generate $400bn by 2032, report reveals
Evaluate’s ‘2026 Orphan Drug Report’ predicts the sales of orphan drugs will continue to rise steadily, despite policy changes and pricing turmoil. According to the forecast, orphan drugs will account for over 21% of all prescription pharmaceutical drugs by 2032.
Read more…
The post This week in Drug Discovery (16 – 20 March) appeared first on Drug Discovery World (DDW).